Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,804
Recruiting: 1,546
Ph III recruiting: 175
Growth YoY: +16.2%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 1,551–1,600 of 1,728 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00022620	Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer	completed	Phase 2	—	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	6	Sep 24, 2012	clinicaltrials
NCT00027794	Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer	completed	Phase 2	40	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	3	Sep 24, 2012